Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-20

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approves Eugia US LLC's original generic application for ketorolac tromethamine, authorizing its marketing as a non-steroidal anti-inflammatory pain relieve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)